Press Releases

• XCE853 is Oregon Therapeutic’s first-in-class, and potentially best-in-class PDI inhibitor, exhibiting potent preclinical efficacy across multiple solid and hematological cancers, and is ready to advance to Investigational New Drug (IND)-enabling development.
• The AI-enabled collaboration aims to refine and expand the positioning of XCE853, a novel protein disulfide isomerase (PDI) inhibitor, in new and targeted oncology indications, including for drug-resistant... (continue reading...)

HONG KONG, May 6, 2024 /PRNewswire/ -- OKX Ventures, the investment arm of leading crypto exchange and Web3 technology company OKX, has announced a strategic investment in four consumer-oriented products from Web3 venture studio EVG. These include multi-chain SocialFi infrastructure Open Social Protocol, decentralized collaboration network Zeek, strategy card game Legend of Arcadia and real-time strategy game Last Odyssey.

... (continue reading...)

WOODBURY, Minn. & ST. LOUIS--(BUSINESS WIRE)-- Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, today announced its investment in a second manufacturing line for the production of pressurized metered-dose inhaler (pMDI) products containing low-GWP (Global Warming Potential) propellants in its Loughborough, U.K., facility.

This new line will be capable of handling both HFA-152a and HFO-1234ze propellants — that have a GWP of... (continue reading...)

NEW TAIPEI CITY, Taiwan--(BUSINESS WIRE)-- The SINOX Group will showcase the brand-new technology, the Synlox e-security system, at this year's Eurobike exhibition. This initiative leads the traditional lock industry and aims to provide E-bikes with more comprehensive protection.

SINOX Group will showcase the brand-new technological innovation - the Synlox e-security system at the 2024 Eurobike exhibition. Synlox represents an advanced E-bike security solution,... (continue reading...)

Now in beta, Rimsys Intel will leverage the strong expertise of RAPS RAC holders as part of an innovative, community-driven approach to regulatory intelligence.

BERLIN--(BUSINESS WIRE)-- Rimsys, a leading regulatory information management software for the medtech industry, announced today the beta launch of its community-driven, centralized hub for global regulatory intelligence data, Rimsys Intel. Rimsys Intel builds upon Rimsys’ mission of increasing the... (continue reading...)